Dr. Ravi Salgia on the CollabRx System for Matching Patients with Mutations to Clinical Trials
May 1, 2013 ·
1m 24s
Dr. Ravi Salgia, University of Chicago, describes the CollabRx system, which matches patients with particular mutations to appropriate clinical trials.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
